Incyte Corp. (INCY) announced that it reached a multi-year research support and collaboration agreement with Vanderbilt-Ingram Cancer Center or VICC at Vanderbilt University Medical Center or VUMC, whereby Incyte will provide funding for certain aspects of Vanderbilt's cancer research activities.
The alliance is designed to develop an improved understanding of basic cancer biology and the mechanisms of action of certain Incyte-proprietary compounds, as well as identify and develop novel approaches to patient selection which may enable new therapeutic opportunities in oncology.
For comments and feedback: editorial@rttnews.com